Generative AI Could Support Precision Oncology Decision‑Making, Review Suggests

A new scientific review suggests that it could play a growing role in supporting treatment decisions in a field of cancer care that tailors therapies to the genetic and molecular characteristics of each patient’s tumor.

Researchers say generative AI systems may help physicians analyze large volumes of complex medical data, enabling more informed and personalized cancer treatment strategies.

Supporting Complex Cancer Decisions

Precision oncology relies on analyzing detailed patient data, including genomic information, medical history, and clinical research findings. Interpreting this information can be challenging because of the sheer volume of available data.

Generative AI tools may help clinicians process these datasets and summarize relevant insights, assisting doctors in identifying potential treatment options.

Potential Applications in Oncology

According to the review, AI‑powered systems could support oncologists in several ways, including analyzing research literature, identifying genetic mutations in tumors, and suggesting personalized therapy strategies.

These tools may also help match patients with suitable clinical trials or emerging targeted therapies.

Enhancing, Not Replacing, Clinical Expertise

Researchers emphasize that AI technologies are intended to support—not replace—physicians’ expertise. Medical professionals would still be responsible for evaluating AI‑generated insights and making final treatment decisions.

Ensuring transparency, reliability, and data security will be essential for integrating AI systems safely into cancer care.

Future Outlook for AI in Cancer Care

Experts say continued research and clinical validation will be needed before generative AI becomes widely used in routine oncology practice.

However, the review highlights the growing potential of advanced digital tools to help healthcare providers navigate complex medical data and deliver more personalized cancer treatments.